1. Home
  2. BOLT vs WETH Comparison

BOLT vs WETH Comparison

Compare BOLT & WETH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLT
  • WETH
  • Stock Information
  • Founded
  • BOLT 2015
  • WETH 1992
  • Country
  • BOLT United States
  • WETH China
  • Employees
  • BOLT N/A
  • WETH N/A
  • Industry
  • BOLT Biotechnology: Pharmaceutical Preparations
  • WETH
  • Sector
  • BOLT Health Care
  • WETH
  • Exchange
  • BOLT Nasdaq
  • WETH Nasdaq
  • Market Cap
  • BOLT 22.6M
  • WETH 21.5M
  • IPO Year
  • BOLT 2021
  • WETH N/A
  • Fundamental
  • Price
  • BOLT $0.44
  • WETH $1.46
  • Analyst Decision
  • BOLT Hold
  • WETH
  • Analyst Count
  • BOLT 5
  • WETH 0
  • Target Price
  • BOLT $1.25
  • WETH N/A
  • AVG Volume (30 Days)
  • BOLT 105.0K
  • WETH 118.0K
  • Earning Date
  • BOLT 03-20-2025
  • WETH 03-18-2025
  • Dividend Yield
  • BOLT N/A
  • WETH N/A
  • EPS Growth
  • BOLT N/A
  • WETH N/A
  • EPS
  • BOLT N/A
  • WETH 0.34
  • Revenue
  • BOLT $9,779,000.00
  • WETH $41,024,264.00
  • Revenue This Year
  • BOLT $9.87
  • WETH N/A
  • Revenue Next Year
  • BOLT N/A
  • WETH N/A
  • P/E Ratio
  • BOLT N/A
  • WETH $4.25
  • Revenue Growth
  • BOLT 35.86
  • WETH 2.86
  • 52 Week Low
  • BOLT $0.42
  • WETH $1.13
  • 52 Week High
  • BOLT $1.56
  • WETH $5.10
  • Technical
  • Relative Strength Index (RSI)
  • BOLT 36.26
  • WETH 45.91
  • Support Level
  • BOLT $0.42
  • WETH $1.28
  • Resistance Level
  • BOLT $0.48
  • WETH $1.47
  • Average True Range (ATR)
  • BOLT 0.03
  • WETH 0.10
  • MACD
  • BOLT -0.00
  • WETH -0.00
  • Stochastic Oscillator
  • BOLT 16.00
  • WETH 51.43

About BOLT Bolt Biotherapeutics Inc.

Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.

Share on Social Networks: